My bookmarksSign up free

Commission Implementing Regulation (EU) 2023/2596 of 21 November 2023 renewing the approval of propiconazole as an active substance for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Implementing Regulation (EU) 2023/2596 of 21 November 2023 renewing the approval of propiconazole as an active substance for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Implementing Regulation (EU) 2023/2596 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The approval of propiconazole as an active substance for use in biocidal products of product-type 8 is renewed, subject to the conditions set out in the Annex.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Expiry date of approval Product type Specific conditions Propiconazole IUPAC name: (2RS,4RS;2RS,4SR)-1-[[2-(2,4-dichlorophenyl)-4-propyl–1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole EC No: 262-104-4 CAS No: 60207-90-1 Minimum purity of the active substance evaluated: 950 g/kg. 30 November 2030 8 Propiconazole is a candidate for substitution in accordance with Article 10(1), points (a), (d) and (e), of Regulation (EU) No 528/2012. The authorisation of biocidal products using propiconazole as an active substance is subject to the following conditions: (a) the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance; (b) pursuant to point 10 of Annex VI to Regulation (EU) No 528/2012, the product assessment shall include an evaluation as to whether the condition set out in Article 5(2), point (c), of Regulation (EU) No 528/2012 is satisfied; (c) products may only be authorised for use in Member States where the condition set out in Article 5(2), point (c), of Regulation (EU) No 528/2012 is satisfied; (d) the use of biocidal products containing propiconazole shall be subject to appropriate measures to ensure that exposure of humans, animals and the environment to propiconazole is minimised as far as possible; (e) products may only be authorised for: (i) temporary treatment against wood-discolouring fungi (anti-sapstain use through industrial treatment); (ii) industrial and professional treatment of structural wood (wood used in a loadbearing capacity in buildings and structures where the strength of the timber is the primary consideration, such as sheds, joists, bridges, jetties, poles, decking, fence poles, etc.) in use class  ( 2 ) 3 (situation in which the wood or wood-based product is above ground and exposed to the weather, particularly rain) and use class 4 (situation in which the wood or wood-based product is in direct contact with ground or fresh water); (iii) industrial and professional treatment of joinery (wood products coming from the practice of physically joining pieces of wood together, such as windows, doors, rooflights, cladding, lining boards, cover floors, fence rails, etc.) in use class 2 (situation in which the wood or wood-based product is under cover and not exposed to the weather, particularly rain and driven rain, but where occasional, but not persistent, wetting can occur) and use class 3; (iv) in situ brush, spraying or injection applications by professional users of wood in use classes 2 and 3; in situ spraying applications are authorised for indoor use only; (f) in view of the risks identified for the uses assessed, the product assessment shall pay particular attention to: (i) industrial and professional users; (ii) the soil compartment; (iii) groundwater; (g) labels and, where provided, safety data sheets of products authorised shall indicate that industrial application shall be conducted within a contained area or on impermeable hard standing with bunding, that freshly treated timber shall be stored after treatment under shelter or on impermeable hard standing, or both, to prevent direct losses to soil, sewer or water, and that any losses from the application of the product shall be collected for reuse or disposal; (h) labels and, where provided, safety data sheets of products authorised shall indicate that for in situ treatment at a site outdoors, the soil shall be protected with a plastic foil or tray, and that any losses from the application of product shall be collected and disposed by safe means; (i) Member States competent authorities shall specify in the summary of the biocidal product characteristics of a biocidal product containing propiconazole the relevant instructions for use and precautions to be indicated on the label of the treated articles under Article 58(3), point (e), of Regulation (EU) No 528/2012, including a statement that wood treated with propiconazole shall not be used to produce furniture and play structures; precautions shall also include appropriate measures to be taken to reduce leaching and minimise exposure of humans, animals and the environment to propiconazole as far as possible. The placing on the market of treated articles treated with or incorporating propiconazole is subject to the following conditions: (a) as from 1 July 2024, treated articles treated with or incorporating propiconazole may be placed on the market only for use as: (i) wood treated for protection against wood-discolouring fungi (anti-sapstain industrial treatment); (ii) structural wood for use class 3 (situation in which the wood or wood-based product is above ground and exposed to the weather, particularly rain) and use class 4 (situation in which the wood or wood-based product is in direct contact with ground or fresh water); (iii) joinery for use class 2 (situation in which the wood or wood-based product is under cover and not exposed to the weather, particularly rain and driven rain, but where occasional, but not persistent, wetting can occur) and use class 3; (b) as from 1 July 2024, treated articles treated with or incorporating propiconazole shall not be placed on the market for the production of furniture and play structures; (c) the person responsible for the placing on the market of a treated article treated with or incorporating propiconazole shall ensure that the label of that treated article provides the information listed in Article 58(3), second subparagraph, of Regulation (EU) No 528/2012, including a statement as from 1 July 2024 that wood treated with propiconazole shall not be used to produce furniture and play structures. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product made available on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance. ( 2 )   The use classes described in EN 335:2013 are defined in terms of service conditions, with reference to the generalised moisture content and the prevailing biological agents of deterioration (ECHA Guidance on the Biocidal Products Regulation, Volume II: Efficacy, Parts B+C: Assessment and Evaluation, Version 5.0, November 2022).

Other acts of the same type
Regulation (EU) 2024/1679 of the European Parliament and of the Council of 13 June 2024 on Union guidelines for the development of the trans-European transport network, amending Regulations (EU) 2021/1153 and (EU) No 913/2010 and repealing Regulation (EU) No 1315/2013 (Text with EEA relevance)Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence and amending Regulations (EC) No 300/2008, (EU) No 167/2013, (EU) No 168/2013, (EU) 2018/858, (EU) 2018/1139 and (EU) 2019/2144 and Directives 2014/90/EU, (EU) 2016/797 and (EU) 2020/1828 (Artificial Intelligence Act) (Text with EEA relevance)Regulation (EU) 2024/1717 of the European Parliament and of the Council of 13 June 2024 amending Regulation (EU) 2016/399 on a Union Code on the rules governing the movement of persons across bordersRegulation (EU) 2024/1735 of the European Parliament and of the Council of 13 June 2024 on establishing a framework of measures for strengthening Europe’s net-zero technology manufacturing ecosystem and amending Regulation (EU) 2018/1724 (Text with EEA relevance)Regulation (EU) 2024/1747 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2019/942 and (EU) 2019/943 as regards improving the Union’s electricity market design (Text with EEA relevance)Regulation (EU) 2024/1781 of the European Parliament and of the Council of 13 June 2024 establishing a framework for the setting of ecodesign requirements for sustainable products, amending Directive (EU) 2020/1828 and Regulation (EU) 2023/1542 and repealing Directive 2009/125/EC (Text with EEA relevance)Regulation (EU) 2024/1787 of the European Parliament and of the Council of 13 June 2024 on the reduction of methane emissions in the energy sector and amending Regulation (EU) 2019/942 (Text with EEA relevance)Regulation (EU) 2024/1789 of the European Parliament and of the Council of 13 June 2024 on the internal markets for renewable gas, natural gas and hydrogen, amending Regulations (EU) No 1227/2011, (EU) 2017/1938, (EU) 2019/942 and (EU) 2022/869 and Decision (EU) 2017/684 and repealing Regulation (EC) No 715/2009 (recast) (Text with EEA relevance)Regulation (EU) 2024/1849 of the European Parliament and of the Council of 13 June 2024 amending Regulation (EU) 2017/852 on mercury as regards dental amalgam and other mercury-added products subject to export, import and manufacturing restrictions (Text with EEA relevance)Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (Text with EEA relevance)Regulation (EU) 2024/1938 of the European Parliament and of the Council of 13 June 2024 on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC (Text with EEA relevance)Commission Implementing Regulation (EU) 2024/1664 of 12 June 2024 fixing the adjustment rate for direct payments pursuant to Regulation (EU) 2021/2116 of the European Parliament and of the Council in respect of the calendar year 2024

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next